Barriers and Challenges to Making Referrals for Treatment and Services for Opioid Misuse in Family Planning Settings
Authors:
- 1 January 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Women's Health
- Vol. 31 (1) , 38-46
Abstract
Background: In this opioid overdose epidemic, women are an overlooked group seeing increasing rates of overdose death. Implementation challenges have prevented evidence-based interventions from effectively reaching women who misuse opioids, with gaps in access to effective treatment and services. Family planning clinics could serve as important points of contact for referral to needed treatments and services. The study explores how family planning staff knowledge and attitudes related to opioid misuse serve as potential barriers and challenges in making referrals for evidence-based services and treatments. Methods: In 2018, we conducted a national online survey of family planning staff, assessing knowledge and attitudes of treatments and services for opioid misuse. Results: A total of 691 family planning staff completed the survey. Most respondents agreed that opioid misuse was a major problem in their community (86.0%) and identified challenges in responding to it, including a lack of treatment access (70.3%), the absence of in-house behavioral health staff (67.2%), and unfamiliarity with local treatment providers (54.1%). Respondents reported low levels of acceptability for syringe services programs (46.0%), medications such as methadone and buprenorphine (55.4%), and naloxone to reverse opioid overdose (60.1%). Controlling for other factors, race/ethnicity, urbanicity, workplace role, and substance use training were associated with differences in acceptability. Conclusions: Family planning settings could play a critical role in connecting women who misuse opioids to treatment and services. Strategies are needed to increase the acceptability of evidence-based interventions and the feasibility of having family planning staff play a linkage role.Keywords
This publication has 40 references indexed in Scilit:
- Sex differences in the neurobiology of drug addictionExperimental Neurology, 2014
- HIV Risk Reduction With Buprenorphine–Naloxone or MethadoneJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Medication-Assisted Therapies — Tackling the Opioid-Overdose EpidemicNew England Journal of Medicine, 2014
- Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysisInternational Journal of Epidemiology, 2013
- Internal Medicine Residents’ Training in Substance Use Disorders: A Survey of the Quality of Instruction and Residents’ Self-Perceived Preparedness to Diagnose and Treat AddictionSubstance Abuse, 2013
- High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic reviewBMC Public Health, 2013
- Specialized Family Planning Clinics in the United States: Why Women Choose Them and Their Role in Meeting Women's Health Care NeedsWomen's Health Issues, 2012
- Integrating Addiction Medicine Into Graduate Medical Education in Primary Care: The Time Has ComeAnnals of Internal Medicine, 2011
- Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation scienceImplementation Science, 2009
- Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies.Psychology of Addictive Behaviors, 2003